Shoulder Surgery for Shoulder Dislocation
(ATRASI Trial)
Trial Summary
What is the purpose of this trial?
The objective of this study is to investigate arthroscopic treatments of recurrent anterior shoulder instability. Functional outcomes of arthroscopic anatomic glenoid reconstruction with bone graft will be compared to the gold standard, arthroscopic Bankart repair. The investigators hypothesize that arthroscopic anatomic glenoid reconstruction with bone graft will provide better functional outcomes and decreased risk of recurrent dislocation/subluxation. This will be a single center, double blinded, randomized controlled trial performed in Halifax, Nova Scotia, Canada. The primary outcome measured will be the Western Ontario Shoulder Instability (WOSI) score. Secondary outcomes will be subluxation, re-dislocation, and range of motion. A minimum of 200 patients will be enrolled in the study as determined by sample size calculation. Routine radiographs as well as a pre-operative CT with 3D reconstruction and MRI are obtained for all patients. The patients will then undergo a clinical examination and complete a variety of functional and quality of life surveys. Randomization will be based on surgeon skill. Two groups (Bankart repair and anatomic glenoid reconstruction) will be selected with 100 subjects each. Postoperatively, patients in both groups will follow a standardized rehabilitation protocol. The patient will follow-up with the attending surgeon at 2 weeks post-operatively for a wound check. At the 3, 6, 12, and 24 month visits the patient will again undergo the structured clinical examination conducted by a physiotherapist who is blinded to the patients' treatment group. The patient will also complete the questionnaires at each of these follow-up appointments. Complications, and subluxation/dislocation events will be documented at each follow-up evaluation. On the basis of a clinical examination and patient history, the surgeon will diagnose recurrent instability and categorize it as a traumatic or atraumatic subluxation or dislocation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Anatomic Glenoid Reconstruction, AGR, Anatomic Glenoid Reconstruction Procedure, Arthroscopic Bankart Repair for shoulder dislocation?
The study on Bankart reconstruction showed that 94% of patients regained normal shoulder stability after the procedure, indicating its effectiveness in treating recurrent shoulder dislocation. Additionally, the use of suture anchors in the procedure simplified the surgery without specific complications.12345
Is shoulder surgery for dislocation generally safe?
Research shows that shoulder surgeries like Arthroscopic Anatomic Glenoid Reconstruction and Arthroscopic Bankart Repair have similar safety profiles, with complications such as infection and stiffness being rare. Using bone grafts from the iliac crest is considered safe, though donor site issues can occur.16789
How does the Anatomic Glenoid Reconstruction treatment differ from other treatments for shoulder dislocation?
The Anatomic Glenoid Reconstruction (AGR) treatment is unique because it involves reconstructing the glenoid (the socket part of the shoulder joint) to restore stability, which is particularly beneficial for patients with bone defects. This approach differs from the standard Bankart repair, which primarily focuses on soft tissue repair without addressing bone loss.134810
Research Team
Ivan H Wong, MD
Principal Investigator
Nova Scotia Health Authority
Eligibility Criteria
This trial is for individuals who have experienced at least two documented shoulder dislocations. It's not suitable for those with multidirectional instability, pregnancy, paralysis of the shoulder, cancer, severe systemic illness, uncontrolled diabetes (Hgb A1C >7%), previous surgery on the affected shoulder or posterior instability.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
Routine radiographs, CT, and MRI are obtained; baseline data and questionnaires are collected
Surgical Treatment
Participants undergo either arthroscopic Bankart repair or anatomic glenoid reconstruction
Postoperative Rehabilitation
Standardized rehabilitation protocol including immobilization and staged recovery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Anatomic Glenoid Reconstruction
- Arthroscopic Bankart Repair
Anatomic Glenoid Reconstruction is already approved in European Union, United States for the following indications:
- Anterior shoulder instability
- Glenoid bone loss
- Recurrent shoulder dislocations
- Glenoid bone loss
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor